Active Pharmaceutical Ingredient (API)
Imatinib Mesylate
Tyrosine Kinase Inhibitor (TKI)
A revolutionary drug used to treat certain cancers, primarily Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). It is a Tyrosine Kinase Inhibitor (TKI) that selectively blocks the activity of the abnormal $\text{BCR-ABL}$ protein, which drives CML cell proliferation. It is a cornerstone of targeted cancer therapy.
Technical Profile
- Reference Code
- IMA211
- CAS Number
- 220127-57-1
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Imatinib Mesylate as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||